Trxade Health announced that the company received a notice from Nasdaq indicating that because the company had not yet filed its annual report on Form 10-K for the 2023 fiscal year, the company was not compliant with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250, which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MEDS:
